Total Parathyroidectomy with Subcutaneous Parathyroid Forearm Autotransplantation in the Treatment of Secondary Hyperparathyroidism: A Single-Center Experience
Table 2
Comparison of group that underwent total PTX with subcutaneous forearm AT and group that underwent total PTX with subcutaneous intramuscular forearm AT.
Intramuscular group
Subcutaneous group
value
Male
6 (37.5)
8 (36.4)
0.105
Age (year)
51 ± 14
60 ± 12
0.275
Dialysis vintage (months)
89 ± 37
73 ± 47
0.386
Pre-iPTH (pg/ml)
1750 ± 619
1527 ± 451
0.079
Post-iPTH (pg/ml)
63 ± 78
53 ± 66
0.831
<10
3 (18.8)
5 (22.7)
0.767
10–70
11 (68.8)
15 (68.2)
0.970
>70
2 (12.2)
2 (9.1)
0.919
6 months iPTH (pg/ml)
58 ± 66
53 ± 68
0.879
<10
0 (0.0)
1 (4.5)
0.387
10–70
15 (93.8)
20 (90.9)
0.748
>70
1 (6.3)
1 (4.5)
0.816
12 months iPTH (pg/ml)
60 ± 71
52 ± 69
0.819
24 months iPTH (pg/ml)
63 ± 77
53 ± 69
0.746
36 months iPTH (pg/ml)
64 ± 81
54 ± 74
0.756
60 months iPTH (pg/ml)
66 ± 101
57 ± 89
0.708
Follow-up time after PTX + AT (months)
106 ± 24
103 ± 18
0.710
Long-term hypoparathyroidism
0 (0.0)
1 (4.5)
0.387
Persistent hyperparathyroidism
1 (6.3)
1 (4.5)
0.816
Recurrence hyperparathyroidism
1 (6.3)
1 (4.5)
0.816
Autograftectomy
1 (6.3)
2 (9.1)
0.748
Data are show as mean ± standard deviation or number (%). Abbreviations: PTX: total parathyroidectomy; AT: autotransplantation; Pre-iPTH: preoperative intact-parathyroid hormone; Post-iPTH: postoperative intact-parathyroid hormone; 6, 12, 24, 36, and 60 months iPTH: intact-parathyroid hormone measurement at 6, 12, 24, 36, and 60 months after PTX + AT.
